Volume 18, Number 7—July 2012
Outbreak-associated Vibrio cholerae Genotypes with Identical Pulsotypes, Malaysia, 2009
A cholera outbreak in Terengganu, Malaysia, in November 2009 was caused by 2 El Tor Vibrio cholerae variants resistant to typical antimicrobial drugs. Evidence of replacement of treatable V. cholerae infection in the region with antimicrobial-resistant strains calls for increased surveillance and prevention measures.
Vibrio cholerae, the causative agent of cholera, is endemic in many parts of the world, especially in countries that lack clean water supplies and adequate public health facilities (1). In Malaysia, cholera outbreaks caused by the El Tor O1 V. cholerae serogroup occur periodically, cases from the 0139 serogroup occur sporadically, and the non–O1/non–O139 V. cholerae serogroup has not been implicated in any major outbreak (2–4). Contaminated drinking water, cooked food, and raw or undercooked seafood served as vehicles of transmission in Malaysia (5).
In November 2009, a cholera outbreak occurred in Terengganu, Peninsular Malaysia. The outbreak began in the capital, Kuala Terengganu, and spread to several districts within a week. Approximately 400 persons were hospitalized for treatment of acute diarrhea and its complications during the outbreak period. One death occurred before the local health authorities declared an outbreak. Five ice factories, 2 fish cracker factories, and several restaurants and street cart food vendors were ordered closed because they were suspected of being possible sources of the outbreak (Ministry of Health, Malaysia, unpub. data).
For this study, 75 rectal swab samples, collected from patients admitted to Hospital Sultanah Nur Zahirah in Kuala Terengganu who had acute diarrhea during the outbreak period, were available for analysis. In addition, 60 environmental samples (6 water samples, 54 environmental swab samples) were collected from 2 of the ice factories (factories A and B) in Kuala Terengganu by the Terengganu State Department of Health during the outbreak period and were provided to us for analysis. Environmental swab samples were obtained from several areas within the ice-making factories. The rectal swab and environmental samples were enriched overnight in alkaline-buffered peptone water, pH 8.6 (Oxoid, Basingstoke, UK) and cultured on thiosulfate citrate-bile salts-sucrose agar (Oxoid). The presumptive colonies were subjected to conventional biochemical tests, such as string, salt tolerance, Voges-Proskauer, lysine iron agar, Kliger iron agar, and arginine dihydrolase testing. PCRs targeting ompW, hlyA, rfb, ctxA, toxR, tcpI, rtxC, rstR, and tcpA genes as described (6,7) were run in parallel to confirm and characterize V. cholerae isolates. Template DNA was also prepared directly from the water samples as described (6) for detection of viable but nonculturable V. cholerae and its virulence genes.
Antimicrobial drug susceptibility of the confirmed V. cholerae isolates was determined by the disk diffusion method according to Clinical and Laboratory Standards Institute guidelines (8). Six antimicrobial agents (Oxoid) were used: ampicillin (10 µg), chloramphenicol (30 µg), ciprofloxacin (5 µg), trimethoprim/sulfamethoxazole (25 µg), erythromycin (15 µg), and tetracycline (30 µg). To determine the genetic relatedness of the isolates, pulsed-field gel electrophoresis (PFGE) was performed according to the established PulseNet protocol (9) and analyzed with BioNumerics 6.0 (Applied Maths, Kortrijk, Belgium); ctxB genotyping was also performed as described (10).
On the basis of conventional biochemical tests and PCR, 37 isolates from the rectal swab samples and 1 isolate from the washroom swab sample of ice factory B were confirmed as V. cholerae, showing an isolation rate of 48.0% for the clinical samples and 1.9% for the environmental samples. In addition, the 37 clinical isolates were identified as El Tor O1 on the basis of Voges-Proskauer tests and were positive for hlyAEl, tcpAEl, rstREl, rtxC, and rfbO1 genes. The ctxA, toxR, and tcpI genes were present in all of the clinical isolates. The isolate from the restroom specimen of factory B was identified as a non–O1/non–O139 V. cholerae strain that had hlyAEl, rstREl, and toxR genes. This finding indicated that this isolate was likely not related to the outbreak in question. No amplification of V. cholerae–specific genes was observed for the DNA extracted directly from the water samples.
Although the environmental non-O1/non-O139 V. cholerae isolate was sensitive to all the antimicrobial agents tested, the 37 clinical O1 V. cholerae isolates were resistant to ampicillin, trimethoprim/sulfamethoxazole, erythromycin, and tetracycline. In Malaysia, tetracycline generally has been considered the drug of choice for cholera treatment; however, it has been replaced by erythromycin because the number of tetracycline-resistant strains has increased since a 1992 outbreak in the state of Kelantan (11). The emergence of erythromycin-resistant isolates in this outbreak will likely contribute to decreased efficacy of erythromycin.
PFGE of NotI-digested chromosomal DNA from all of the human isolates resulted in 1 pulsotype with 24 fragments (≈30 kb to ≈370 kb); the environmental isolate showed a distinct pulsotype (F = 0.83) (Figure 1). PFGE was repeated 2× with identical results. In addition, the pulsotype of the clinical isolates in this study was identical to the pulsotype of an O1 isolate (123/08) from a cholera patient in Kuala Lumpur in 2008 (Figure 1) (12). Isolate 123/08 also showed identical antibiograms with the Terengganu O1 outbreak isolates. This finding suggests that isolate 123/08 and the Terengganu 2009 O1 outbreak isolates were possibly linked.
Several ctxB alleles have been identified among O1 V. cholerae strains on the basis of a few point mutations: 1) classical and El Tor, US Gulf Coast (39His, 46Phe, 68Tyr); 2) El Tor, Australia (39His, 46Leu, 68Tyr); and 3) El Tor, seventh pandemic, and El Tor, Latin American epidemic (39Tyr, 46Phe, 68Ile) (10). Of the 37 isolates, 33 were classified as genotype 3 on the basis of multiple sequence alignments of ctxB (10). Similarly, our previous multilocus sequence typing study (2) subtyped isolate 123/08 as an El Tor biotype characterized by the ctxB3 gene (Figure 2). We postulate that this particular clone has reemerged since its isolation in Kuala Lumpur in 2008 and was likely linked to the 2009 Terengganu outbreak.
Four of the 37 clinical isolates showed amino acid substitutions Tyr39His and Ile68Thr (Figure 2) and were classified as genotype 1. Genotype 1 strains that carry both classical and El Tor rstR allele have been detected in Asian and African countries since the 1990s (13). In 2001, El Tor variant strains that harbored rstREl/ctxB1 superseded the typical El Tor strains in Bangladesh and other Asian countries. Since 2007, outbreaks in Vietnam and Thailand have been mainly caused by El Tor variant strains (7,14). Ang et al. (3) reported that El Tor variant strains could have emerged earlier in Malaysia because 1 such strain was responsible for the 2000 outbreak in Kelantan. In contrast to neighboring countries, our current study indicates that the El Tor strains have not been replaced by El Tor variant strains in Malaysia; typical El Tor strains are still found in this country. In our current study, the isolates could not be differentiated by PFGE, although they belonged to 2 ctxB genotypes. This finding might be attributed to the genetic events resulting in the transfer of the different ctxB alleles among the V. cholerae populations in Malaysia or with the strains from neighboring countries.
The 2009 cholera outbreak in Terengganu was controlled in late November; 187 cases and 1 death were confirmed (www.myhealth.gov.my/myhealth). We found no evidence of an association between 2 ice factories considered as possible sources of infection and the outbreak. The health authorities later ruled out the other ice factories, fish cracker factories, and eateries suspected of being sources and were unable to trace the source of the outbreak.
Two genotypes (ctxB1 and ctxB3) of the El Tor O1 V. cholerae serogroup with identical pulsotypes were likely responsible for the cholera outbreak in Terengganu in late 2009. Our findings support the need for increased surveillance in the region to document the prevalence of such strains. Preventive activities such as water sanitation, public education on proper food handling, and personal cleanliness are crucial to reduce the risk of spread of cholera.
Dr Teh is a postdoctoral research fellow at University of Malaya. Her research interests are surveillance of enteric pathogens, detection of outbreaks, genomic diversity of enteric pathogens with reference to strain evolution, and molecular pathogenesis.
We thank Ahmad Rushdi, Tan Abdullah, and Afandi B Ahmad for technical support; and Hospital Sultanah Nur Zahirah and the State Department of Health, Kuala Terengganu, for the samples.
The study was partially supported by the Higher Impact Research grant (UM.C/625/1/HIR/MOHE/02) from University of Malaya.
- Mandomando I, Espasa M, Valles X, Sacarlal J, Sigauque B, Ruiz J, Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhica District Hospital, southern Mozambique. J Antimicrob Chemother. 2007;60:662–4.
- Teh CSJ, Chua KH, Thong KL. Genetic variation analysis of Vibrio cholerae using multilocus sequencing typing and multi-virulence locus sequencing typing. Infect Genet Evol. 2011;11:1121–8.
- Ang GY, Yu CY, Balqis K, Elina HT, Azura H, Hani MH, Molecular evidence of cholera outbreak caused by a toxigenic Vibrio cholerae O1 El tor variant strain in Kelantan, Malaysia. J Clin Microbiol. 2010;48:3963–9.
- Chen CH, Shimada T, Elhadi N, Radu S, Nishibuchi M. Phenotypic and genotypic characteristics and epidemiological significance of ctx+ strains of Vibrio cholerae isolated from seafood in Malaysia. Appl Environ Microbiol. 2004;70:1964–72.
- Lim VK. Cholera: a re-emerging infection. Med J Malaysia. 2001;56:1–3.
- Teh CSJ, Thong KL, Ngoi ST, Ahmad N, Nair GB, Ramamurthy T. Molecular characterization of serogrouping and virulence genes of Malaysian Vibrio cholerae isolated from different sources. J Gen Appl Microbiol. 2009;55:419–25.
- Okada K, Roobthaisong A, Nakagawa I, Hamada S, Chantaroj S. Genotypic and PFGE/MLVA analyses of Vibrio cholerae O1: geographical spread and temporal changes during the 2007–2010 cholera outbreaks in Thailand. PLoS ONE. 2012;7:e30863.
- Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 18th informational supplement. CLSI document M100–S18. Wayne (PA): The Institute; 2008.
- Centers for Disease Control and Prevention. Pulsenet USA. The national molecular subtyping network for foodborne disease surveillance: rapid standard laboratory protocol for molecular subtyping of Vibrio cholerae by pulse-field gel electrophoresis (PFGE). 2006.
- Olsvik O, Wahlberg J, Petterson B, Uhlen M, Popovic T, Wachsmuth IK, Use of automated sequencing of polymerase chain reaction–generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J Clin Microbiol. 1993;31:22–5.
- Ranjit K, Nurahan M. Tetracycline resistant cholera in Kelantan. Med J Malaysia. 2000;55:143–5.
- Teh CSJ, Chua KH, Thong KL. Multiple-locus variable-number tandem repeat analysis of Vibrio cholerae in comparison with pulsed field gel electrophoresis and virulotyping. J Biomed Biotechnol. 2010;2010:817190.
- Safa A, Nair GB, Kong RY. Evolution of new variants of Vibrio cholerae O1. Trends Microbiol. 2010;18:46–54.
- Tran HD, Alam M, Trung NV, Van Kinh N, Nguyen HH, Pham VC, Multi-drug resistant Vibrio cholerae O1 variant El Tor isolated in northern Vietnam between 2007 and 2010. J Med Microbiol. 2012;61:431–7.
Suggested citation for this article: Teh CSJ, Suhali Z, Lim KT, Khamaruddin MA, Yahya F, Sajili MH, et al. Outbreak-associated Vibrio cholerae genotypes with identical pulsotypes, Malaysia, 2009. Emerg Infect Dis [serial on the Internet]. 2012 Jul [date cited]. http://dx.doi.org/10.3201/eid1807.111656
Comments to the Authors
West Nile Virus RNA
in Tissues from Donor
Transmission to Organ